It was originally isolated in 1977 from the cerebral venous blood of rabbits and has since been found to be present in small amounts in human brains and plasma, with higher concentrations later in the day.3 4 It, or a similar substance, is also present at higher concentrations in human breast milk.5 Because DSIP can cross the blood-brain barrier and is easily absorbed via the gut (unusual for a peptide), some researchers have hypothesized that it may facilitate post-feeding sleep tendencies among newborns, though it remains unclear whether DSIP truly has a hand in neonate sleep-wake cycles.4 5 6 Its mechanism of action is likewise unclear, but it may have something to do with endocrine regulation
Gastrointestinal Research Much of the initial work focused on the digestive tract
Peptide Reconstitution & Injection Calculator How to use it: Select your syringe type, enter your peptide volume and the amount of bac water you added to the vial, then input your target dose
PE-22-28 represents a shorter, optimized fragment of the 28-amino acid spadin peptide that retains TREK-1 blocking activity
Scientific References (External Links) For researchers seeking primary literature on the mechanisms described above: Biomedical Research International: GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration View Study Journal of Physiology and Pharmacology: BPC 157 and blood vessels View Study Annals of the New York Academy of Sciences: Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues View Study
In a two-day marathon hearing that pitted career regulatory representatives against figures of the peptide industry, the Food and Drug Administration voted on July 23 and 24 to recommend the approval of six peptides that had been previously banned for human use under the Biden administration